The sky’s the limit for disruptive innovation in eye research – and our world-leading research makes it possible to help patients who cannot be treated with existing interventions.
In 2004, SERI led a multi-disciplinary team to perform the first ‘tooth in eye’ surgery – called osteo-odonto-keratoprosthesis (OOKP) – in South East Asia to restore sight to a patient with end-stage corneal eye disease. The procedure involves removing a canine tooth from the patient, shaping and drilling it to allow implantation of an artificial plastic corneal device (optical cylinder), and ultimately implanting it back into one eye a few months later. Since then, more than 50 OOKP surgeries have been successfully performed for patients from Australia, Indonesia, Malaysia, Sri Lanka, Thailand, Vietnam and Singapore.
In 2010, our researchers have developed nation-wide innovations such as the
Singapore Integrated Diabetic Retinopathy Programme (SIDRP), which have helped make diabetic eye screening more accessible and efficient for Singaporeans.
Our most recent development involves the usage of an artificial intelligence system to detect 3 eye diseases – diabetic retinopathy, glaucoma, and age-related macular degeneration – from retinal scans. The system, which utilises deep-learning technology, helps speed up the process of eye scanning and enables automated eye screening to be done in remote communities.
On the global stage, a swift response from SNEC clinicians helped to avert an outbreak of blindness caused by the fungal contamination of a well-known
contact lens cleaning solution.
All these would not have been possible without generous funding support.
Help us fund cutting-edge eye research that will reverse the slow fade to blindness experienced by our patients.
Subscribe to our mailing list to get the updates to your email inbox...